X
AMRX icon

Xponance’s Amneal Pharmaceuticals AMRX Stock Holding History

Xponance’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$358K Buy
20,657
+3,101
+18% +$42.5K ﹤0.01% 1305
2026
Q1 		$218K Buy
17,556
+5,706
+48% +$76.6K ﹤0.01% 1432
2025
Q4 		$149K Sell
11,850
-450
-4% -$5.15K ﹤0.01% 1428
2025
Q3 		$123K Sell
12,300
-626
-5% -$5.62K ﹤0.01% 1427
2025
Q2 		$105K Sell
12,926
-257
-2% -$1.94K ﹤0.01% 1407
2025
Q1 		$110K Buy
13,183
+1,828
+16% +$15.3K ﹤0.01% 1333
2024
Q4 		$89.9K Buy
11,355
+961
+9% +$8.06K ﹤0.01% 1377
2024
Q3 		$86.5K Buy
10,394
+180
+2% +$1.41K ﹤0.01% 1328
2024
Q2 		$64.9K Buy
+10,214
New +$64.8K ﹤0.01% 1269

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Xponance's AMRX Position: Q2 2026 in Review

Xponance increased its Amneal Pharmaceuticals (AMRX) stake by 18% in Q2 2026, buying an estimated $42.5K and bringing the position to 20,657 shares worth $358K. The position accounts for ﹤0.01% of the portfolio, ranked #1305.

Xponance first reported a position in AMRX in Q2 2024 and has held it in 9 quarters since. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Xponance held 20,657 shares of Amneal Pharmaceuticals worth $358K as of Q2 2026.
  • Xponance bought 3,101 Amneal Pharmaceuticals shares in Q2 2026, an estimated $42.5K.
  • Amneal Pharmaceuticals made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #1305 holding.
  • Xponance first reported a position in Amneal Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • 311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.